Research and Markets (http://www.researchandmarkets.com/research/grvwvb/otc_pharmaceutical)
has announced the addition of the "OTC
Pharmaceuticals in United Arab Emirates" report to their
OTC Pharmaceuticals in United Arab Emirates industry profile provides
top-line qualitative and quantitative summary information including:
market share, market size (value and volume 2006-10, and forecast to
2015). The profile also contains descriptions of the leading players
including key financial metrics and analysis of competitive pressures
within the market. Essential resource for top-line data and analysis
covering the United Arab Emirates otc pharmaceuticals market. Includes
market size and segmentation data, textual and graphical analysis of
market growth trends, leading companies and macroeconomic information.
-The Emirati OTC pharmaceuticals market generated total revenues of
$230.4 million in 2010, representing a compound annual growth rate
(CAGR) of 9.2% for the period spanning 2006-2010.
-Analgesics sales proved the most lucrative for the Emirati OTC
pharmaceuticals market in 2010, generating total revenues of $49.2
million, equivalent to 21.4% of the market's overall value.
-The performance of the market is forecast to decelerate, with an
anticipated CAGR of 6.3% for the five-year period 2010-2015.
Johnson & Johnson
For more information visit http://www.researchandmarkets.com/research/grvwvb/otc_pharmaceutical